Commercial Name: External Drainage Catheter Antimicrobial LCR ## Record Number: 10175060026 ## Technical Name: Drainage System ## Risk Class: IV (Maximum Hazard) ## Models: 04019724- Antimicrobial LCR External Drainage Catheter - Adult Model , 04019725 - LCR Antimicrobial External Drainage Catheter - Neonatal Model 의 안전성 경고

Agência Nacional de Vigilância Sanitária (ANVISA)에 따르면, 해당 안전성 경고 는 Brazil 에서 Ventura Biomédica Ltda. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 사례 ID
    1982
  • 날짜
    2016-09-14
  • 사례 국가
  • 사례 출처
    ANVISA
  • 사례 출처 URL
  • 비고 / 경고
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • 데이터 추가 비고
    Recommendations: 1. Segregate products in stock; If you wish to notify technical complaints and adverse events, please use the following channels: Notivisa: Notices of adverse events (AEs) and technical complaints (QT) for products subject to Sanitary Surveillance should be sent to the manufacturer for later disposal (de-characterization / destruction) made through the NOTIVISA System. To access the System, you must register and select the Health Professional option, if you are a liberal professional or the Institution / Entity option, if you are a professional of an institution / entity. Technovigilance System: Patient or citizen can notify through the Technovigilance System / SISTEC access through the link ## UPDATE ## Field Action Closing: 12/12/2016. According to the report sent by the company, the products collected from customers and those that were in the company's stock were decharacterized.
  • 원인
    During inspection by entities of the national system of sanitary surveillance (snvs) it was evidenced that the company was manufacturing and marketing product in disagreement with the specifications of the project and in disagreement with its registration with anvisa.
  • 조치
    Field action 204/2016 triggered under the responsibility of Ventura Biomédica Ltda. - CNPJ: 57.182.230 / 0001-36, which involved the immediate stoppage of the manufacturing and marketing of the product; communication to customers for blocking commercialization and use, recollection for later destruction / decharacterization.

Manufacturer